Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opportunities and Challenges for Surveillance of Congenital Anomalies in Sub-Saharan Africa.

Birth defects research·2026
Same author

Emerging Dolutegravir Resistance Among Children on Antiretroviral Therapy With Virological Failure in Malawi: Results From a 2023 National Cross-Sectional Survey.

Journal of the International AIDS Society·2026
Same author

Monitoring COVID-19 occurrence in a resource-limited setting - COVID-19 sentinel surveillance in Malawi.

PLOS global public health·2026
Same author

HIV Drug Resistance to Dolutegravir Among Adults Investigated for Antiretroviral Treatment Failure in Malawi: A 2023 National Cross-Sectional Survey.

Journal of acquired immune deficiency syndromes (1999)·2025
Same author

Excess mortality associated with HIV: Survey estimates from the PHIA project.

Demographic research·2025
Same author

Cost of the typhoid conjugate vaccine introduction through an integrated campaign and follow-on routine immunization in Malawi.

Vaccine: X·2024

Related Experiment Video

Updated: Jul 8, 2026

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

The Malawi National Tuberculosis Programme: an equity analysis.

Bertha Nhlema Simwaka1, George Bello, Hastings Banda

  • 1Research for Equity And Community Health Trust, Area 3 Mtunthama Drive, Lilongwe, Malawi. bertha@equi-tb-malawi.org.

International Journal for Equity in Health
|January 1, 2008
PubMed
Summary

Malawi

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Related Experiment Videos

Last Updated: Jul 8, 2026

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Area of Science:

  • Public Health
  • Epidemiology
  • Health Services Research

Background:

  • Malawi's National Tuberculosis Control Programme transitioned from a vertical model to a Sector Wide Approach (SWAp) in 2005.
  • This shift presents new opportunities for monitoring the program's equity performance.
  • This paper synthesizes existing knowledge on tuberculosis (TB) and equity in Malawi, identifying areas for future action.

Purpose of the Study:

  • To synthesize current knowledge on TB and equity in Malawi.
  • To identify gaps and areas for advocacy within the TB control program.
  • To inform strategies for improving equitable access to TB services.

Main Methods:

  • A comprehensive synthesis of published and unpublished reports and studies.
  • Analysis of routine data on access to TB services.
  • Consultation with Malawian stakeholders and a review of international literature.

Main Results:

  • A lack of prevalence surveys hinders epidemiological understanding of TB and vulnerability.
  • TB cases surged from 5,334 in 1985 to 28,000 in 2006, largely due to HIV/AIDS (77% of TB patients are HIV-positive).
  • High costs and diagnostic complexities impede access and adherence for the poor; only 48% of TB cases are detected.

Conclusions:

  • The SWAp offers a valuable opportunity to improve equity and pro-poor health services.
  • Increasing case detection, particularly among the poor, is crucial for addressing 'missing cases'.
  • A national TB prevalence survey is essential for robust equity monitoring and targeted interventions.